One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Itamar Medical Ltd. logo
Itamar Medical Ltd. ITMR

Itamar Medical Ltd. Balance Sheet 2020-2011 | ITMR

Brief overview of Itamar Medical Ltd.'s balance sheet structure

The review uses the five latest available annual reports between 2016 and 2020.

The asset base grew from $35.5 million to $64.1 million, or +80.4%. Average annual growth of roughly 15.9% was strong.

Growth in the asset base was not matched by liabilities: +80.4% versus -30.5%. The balance sheet moved in a more conservative direction.

Cash exceeds interest-bearing debt, producing net debt of -$2.3 million. The balance sheet therefore carries a net cash position.

The balance sheet carries negative retained earnings of -$119.1 million. The figure may result from accumulated losses or an active capital return policy.

What the balance sheet shows

Itamar Medical Ltd.'s financial position is more positive than negative: the funding mix is workable, although the cushion is not unlimited.

Annual Balance Sheet Itamar Medical Ltd.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-2.3 M -15.1 M -1.47 M 3.05 M -5.57 M -18.1 M 5.15 M 7.99 M - -

Long Term Debt

154 K - - - 8.17 M 14.9 M 14.6 M 12.7 M - -

Total Non Current Liabilities

3.08 M - 1.65 M 4.13 M 16 M 22.2 M 24.6 M 27 M - -

Total Current Liabilities

18 M 13.3 M 10.1 M 15.8 M 14.3 M 4.62 M 4.71 M 11.4 M - -

Total Liabilities

21.1 M 16.5 M 11.7 M 19.9 M 30.3 M 26.8 M 29.3 M 38.4 M - -

Deferred Revenue

732 K 1.03 M 255 K 193 K 158 K 200 K 95 K 84 K - -

Retained Earnings

-119 M -110 M -106 M -105 M -101 M -88.2 M -86.2 M -84.4 M - -

Total Assets

64.1 M 33.2 M 18.4 M 21.3 M 35.5 M 43.7 M 24.6 M 23.8 M - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Itamar Medical Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.43 -4.89 % $ 1.03 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 61.34 5.7 % $ 9.31 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 90.02 -1.23 % $ 4.91 B britainBritain
Profound Medical Corp. Profound Medical Corp.
PROF
$ 7.22 4.94 % $ 218 M canadaCanada
LENSAR LENSAR
LNSR
$ 5.44 -1.09 % $ 65.1 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 7.87 -11.77 % $ 312 M curacaoCuracao
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 2.56 -0.59 % $ 104 M usaUSA
InspireMD InspireMD
NSPR
$ 0.71 11.49 % $ 45.7 M israelIsrael
InMode Ltd. InMode Ltd.
INMD
$ 13.34 -0.45 % $ 862 M israelIsrael
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 31.72 -1.55 % $ 744 M usaUSA
Outset Medical Outset Medical
OM
$ 4.24 3.41 % $ 64.5 M usaUSA
PAVmed PAVmed
PAVM
$ 1.58 1.61 % $ 1.06 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 16.6 5.87 % $ 462 M australiaAustralia
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 7.35 -0.81 % $ 993 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 63.96 -3.73 % $ 1.88 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.6 -0.11 % $ 4.4 B usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.95 0.78 % $ 43 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
- - $ 140 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
Align Technology Align Technology
ALGN
$ 164.4 3.16 % $ 11.9 B usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 110.03 -3.18 % $ 192 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 382.08 3.5 % $ 10.4 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 102.08 1.29 % $ 59.7 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 7.44 -4.62 % $ 1.12 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 101.83 -2.9 % $ 131 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.31 0.91 % $ 489 M usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.1 0.06 % $ 591 M israelIsrael
Myomo Myomo
MYO
$ 1.21 1.68 % $ 50.6 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 51.44 -2.42 % $ 1.6 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.24 -3.95 % $ 15.5 M israelIsrael
Penumbra Penumbra
PEN
$ 319.32 -0.59 % $ 12.4 B usaUSA